MedPath

Clinical investigation of the effects of pioglitazone in the diabetic patients with hemodilaysis

Not Applicable
Conditions
Diabetic patients with hemodialysis
Registration Number
JPRN-UMIN000002643
Lead Sponsor
ihon University Nerima Hikarigaoka Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

The exclusion criteria are the patients treated with insulin, cirrhosis or deranged liver function at baseline; prior history of heart failure (both systolic and diastolic), myocardial infarction, or symptomatic coronary artery disease; significant aortic or mitral valve heart disease; New York Heart Association (NYHA) class 3 or 4 cardiac status; thyroid disease, or malignant tumour; history of gastrointestinal or other major bleeding within the last 6 months; and treatment with steroids.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath